Charnita Zeigler‐Johnson

ORCID: 0000-0003-2641-7755
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Global Cancer Incidence and Screening
  • Lung Cancer Diagnosis and Treatment
  • Health Systems, Economic Evaluations, Quality of Life
  • Hormonal and reproductive studies
  • Cancer Risks and Factors
  • Genetic Associations and Epidemiology
  • Smoking Behavior and Cessation
  • Cancer, Lipids, and Metabolism
  • Head and Neck Cancer Studies
  • Health disparities and outcomes
  • Colorectal Cancer Screening and Detection
  • Inflammatory Biomarkers in Disease Prognosis
  • Glutathione Transferases and Polymorphisms
  • Advanced Causal Inference Techniques
  • Cervical Cancer and HPV Research
  • Cardiovascular Health and Risk Factors
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Bladder and Urothelial Cancer Treatments
  • Adipokines, Inflammation, and Metabolic Diseases
  • Patient-Provider Communication in Healthcare
  • Cancer-related molecular mechanisms research
  • Molecular Biology Techniques and Applications
  • Nutritional Studies and Diet

Temple University Health System
2024-2025

Fox Chase Cancer Center
2023-2025

Thomas Jefferson University
2014-2024

University of Pennsylvania
2005-2023

Sidney Kimmel Cancer Center
2014-2020

Philadelphia University
2020

Thomas Jefferson University Hospital
2014

Moffitt Cancer Center
2011

University of Southern California
2011

Johns Hopkins University
2011

Prostate cancer (CaP) is the leading among men of African descent in USA, Caribbean, and Sub-Saharan Africa (SSA). The estimated number CaP deaths SSA during 2008 was more than five times that Americans expected to double by 2030. We summarize publicly available data collected from Carcinoma (MADCaP) Consortium Caribbean Cancer (AC3) evaluate incidence mortality worldwide. are highest USA Caribbean. Tumor stage grade were SSA. report a higher proportion T1 prostate tumors countries with...

10.1155/2013/560857 article EN cc-by Prostate Cancer 2013-01-01
Veda N. Giri Karen E. Knudsen William Kevin Kelly Heather H. Cheng Kathleen A. Cooney and 87 more Michael S. Cookson William L. Dahut Scott M. Weissman Howard R. Soule Daniel P. Petrylak Adam P. Dicker Saud H. AlDubayan Amanda E. Toland Colin C. Pritchard Curtis A. Pettaway Mary B. Daly James L. Mohler J. Kellogg Parsons Peter R. Carroll Robert Pilarski Amie Blanco Ashley Woodson Alanna Kulchak Rahm Mary-Ellen Taplin Thomas J. Polascik Brian T. Helfand Colette Hyatt Alicia K. Morgans Felix Y. Feng Michael P. Mullane Jacqueline Powers Raoul S. Concepcion Daniel W. Lin Richard C. Wender James Ryan Mark Anthony J. Costello Arthur L. Burnett Oliver Sartor William B. Isaacs Jianfeng Xu Jeffrey N. Weitzel Gerald L. Andriole Himisha Beltran Alberto Briganti Lindsey Byrne Anne Calvaresi Thenappan Chandrasekar David Y.T. Chen Robert B. Den Albert Dobi E. David Crawford James A. Eastham Scott E. Eggener Matthew L. Freedman Marc B. Garnick Patrick T. Gomella Nathan Handley Mark Hurwitz Joseph K. Izes R. Jeffrey Karnes Costas D. Lallas Lucia R. Languino Stacy Loeb Ana María López Kevin R. Loughlin Grace Lu‐Yao S. Bruce Malkowicz Mark Mann Patrick Mille Martin Miner Todd M. Morgan José Moreno Lorelei A. Mucci Ronald E. Myers Sarah M. Nielsen Brock O’Neil Wayne H. Pinover Peter A. Pinto Wendy Poage Ganesh V. Raj Timothy R. Rebbeck Charles J. Ryan Howard M. Sandler Matthew J. Schiewer Emily Scott Brittany M. Szymaniak William Tester Edouard J. Trabulsi Neha Vapiwala Evan Y. Yu Charnita Zeigler‐Johnson Leonard G. Gomella

Germline testing (GT) is a central feature of prostate cancer (PCA) treatment, management, and hereditary assessment. Critical needs include optimized multigene strategies that incorporate evolving genetic data, consistency in GT indications alternate evaluation models address the rising demand for services. A multidisciplinary consensus conference included experts, stakeholders, national organization leaders was convened response to current practice challenges develop implementation...

10.1200/jco.20.00046 article EN Journal of Clinical Oncology 2020-06-09

Background The association between homocysteine and isolated systolic hypertension in older adults was evaluated using a case-control design, the relationship clinical or subclinical atherosclerosis explored. Methods Results Cases were 179 ≥60 years with blood pressure of ≥160 mm Hg diastolic <90 Hg. One hundred seventy-one control subjects had same criteria except pressures <160 All normal creatinine levels. Homocysteine levels performed on fasting samples that been stored at −70°C....

10.1161/01.cir.96.6.1745 article EN Circulation 1997-09-16

Abstract Background Racial disparities are well-documented in preventive cancer care, but they have not been fully explored the context of lung screening. We sought to explore racial differences screening outcomes within a program (LCSP) at our urban academic medical center including baseline low-dose computed tomography (LDCT) results, time follow-up, adherence, as well return annual after additional imaging, loss and diagnoses patients with positive scans. Methods A historical cohort study...

10.1186/s12885-020-06923-0 article EN cc-by BMC Cancer 2020-06-16

Abstract The CYP3A genes reside on chromosome 7q21 in a multigene cluster. enzyme products of CYP3A4 and CYP3A43 are involved testosterone metabolism. CYP3A5 have been associated previously with prostate cancer occurrence severity. To comprehensively examine the effects these severity, we studied 622 incident cases 396 controls. Substantial race-specific linkage disequilibrium was observed between both races but not other pairs loci. We found no association genotypes or disease CYP3A43*3...

10.1158/0008-5472.can-04-1651 article EN Cancer Research 2004-11-15

Genome-wide association studies have identified multiple genetic variants associated with prostate cancer risk which explain a substantial proportion of familial relative risk. These can be used to stratify individuals by their cancer.

10.1158/1055-9965.epi-14-0317 article EN Cancer Epidemiology Biomarkers & Prevention 2015-04-03

<i>Objectives:</i> Ethnic differences in prostate cancer incidence are well documented, with African-Americans having among the highest rates world. genotypes for genes associated androgen metabolism including <i>SRD5A2</i> and <i>CYP3A4</i> also may exist. The aim of this study was to evaluate these by ethnicity. <i>Methods:</i> We studied cancer-free controls representative four groups: 147 African Americans, 410 Caucasian-Americans, 129...

10.1159/000066695 article EN Human Heredity 2002-01-01

Abstract Reported associations of ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer have been inconsistent understudied in African Americans. We evaluated the role 16 sequence variants these genes using 888 European American 131 cases, 473 163 American, controls. observed significant differences ELAC2, RNASEL, allele frequencies by race. However, we did not observe between any examined for both races combined. Associations were when stratified race, family history, or disease severity....

10.1158/1055-9965.epi-04-0637 article EN Cancer Epidemiology Biomarkers & Prevention 2005-04-01

No AccessJournal of UrologyAdult urology1 Nov 2007Association Obesity With Tumor Characteristics and Treatment Failure Prostate Cancer in African-American European American Menis accompanied byObesity Cancer: Importance Race Stage Disease E. Spangler, C.M. Zeigler-Johnson, M. Coomes, S.B. Malkowicz, A. Wein, T.R. Rebbeck SpanglerE. Spangler Center for Clinical Epidemiology Biostatistics, University Pennsylvania School Medicine, Philadelphia, , Zeigler-JohnsonC.M. Zeigler-Johnson CoomesM....

10.1016/j.juro.2007.07.021 article EN The Journal of Urology 2007-09-18

(1) Background: Lung cancer is the deadliest and second most prevalent in Pennsylvania (PA), African American patients are disproportionately affected. morbidity mortality Philadelphia County among highest PA. Geographic information systems (GIS) useful to explore geospatial variations burden risk factors. Therefore, we used GIS analyze lung assess which areas of city have mortality, identify potential clusters, determine census tract-level characteristics were associated with higher burden....

10.3390/ijerph22030455 article EN International Journal of Environmental Research and Public Health 2025-03-20

Purpose To identify the barriers and facilitators to help seeking, screening for early presentation diagnosis of prostate cancer in Kenya. Methods Seven focus group discussions (FGDs) were held with a total 46 patients diagnosed living cancer, 65% ( n = 30) from public Hospital 35% 16) private hospital. An FGD guide was used collect data on patients' screening, diagnosis. Results The distributed across different age groups: 4.3 % 2) aged 50–59, 41% 19) 60–69, 54% 25) 70 above. majority 7 th...

10.3389/fcacs.2025.1521454 article EN cc-by Frontiers in Cancer Control and Society 2025-03-21

Abstract Background: Cervical cancer is the most prevalent and leading cause of cancer-related deaths among women in Eswatini, which reported world’s highest cervical incidence (95.9 per 100,000) mortality (64.3 rates 2022. Despite this significant burden, screening coverage was limited to 19% as WHO’s 2019 report. This study assessed progress prevalence identified predictors uptake aged 25-59 Eswatini. Method: Data were obtained from 2021 Eswatini Population-based HIV Impact Assessment...

10.1158/1538-7445.am2025-4961 article EN Cancer Research 2025-04-21

Abstract The lung cancer mortality rate in Philadelphia is 16% higher than the national rate, making screening and prevention efforts paramount. To support efforts, Fox Chase Cancer Center operates a comprehensive Tobacco Treatment Program (TTP) that employs an Implementation Science (IS) approach provides over 1000 individuals with various therapeutic strategies to smoking cessation. Using TTP as case study, this brief report describes adaptation of Reach, Effectiveness, Adoption,...

10.1093/jncics/pkaf047 article EN cc-by-nc-nd JNCI Cancer Spectrum 2025-05-08

Background Population history can be reflected in group genetic ancestry, where genomic variation captured by the mitochondrial DNA (mtDNA) and non-recombining portion of Y chromosome (NRY) separate female- male-specific admixture processes. Genetic ancestry may influence association studies due to differences individual within recently admixed populations like African Americans. Principal Findings We evaluated Senegalese as well European Americans from Philadelphia. mtDNA consisted ∼12% U...

10.1371/journal.pone.0007842 article EN cc-by PLoS ONE 2009-11-24

Patient reports of health related quality life can provide important information about the long-term impact prostate cancer. Because patient symptoms and function differ by age survivor, aim our study was to examine patient-reported at diagnosis among a registry Dutch cancer survivors.A population 617 individuals from Reported Outcomes Following Initial Treatment Long-Term Evaluation Survivorship (PROFILES) database surveyed using European Organization for Research Cancer Quality Life...

10.1186/s12889-018-5976-6 article EN cc-by BMC Public Health 2018-08-23

Abstract Background Lung cancer screening uptake for individuals at high risk is generally low across the United States, and reporting of lung practices outcomes often limited to single hospitals or institutions. We describe a citywide, multicenter analysis receiving integrated with geospatial analyses neighborhood-level factors. Methods The Philadelphia Cancer Learning Community consists clinicians researchers 3 largest health systems in city. This multidisciplinary, multi-institutional...

10.1093/jncics/pkad071 article EN cc-by JNCI Cancer Spectrum 2023-08-31

Prostate cancer disparities have been reported in men of African descent who show the highest incidence, mortality, compared with other ethnic groups. Few studies explored genetic and environmental factors for prostate ancestry. The glutathione-S-transferases family conjugates carcinogens before their excretion is expressed tissue. This study addressed role GSTM1 GSTT1 deletions on risk populations descent. multi-institutional case-control gathered data from Genetic Susceptibility to...

10.1093/carcin/bgr119 article EN Carcinogenesis 2011-06-24
Coming Soon ...